Ignite Creation Date:
2024-05-06 @ 7:34 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06064006
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2023-09-11
Brief Title:
A Research Study to See How a New Medicine NNC0487-0111 Works in People With Overweight or Obesity When Injected Under the Skin
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
A Randomised Placebo-controlled and Double-blinded Study Assessing the Safety Tolerability Pharmacokinetics and Efficacy of Subcutaneous Administrations of NNC0487-0111 in Participants With Overweight or Obesity
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to evaluate if a new study drug NNC0487-0111 is safe and how it works in the participants body when given as injections under the skin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U1111-1289-3282 | OTHER | World Health Organization WHO | None |